(IRON) Disc Medicine - Performance 26.6% in 12m
IRON performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-54.14%
#81 in Peer-Group
Rel. Strength
65.45%
#2661 in Stock-Universe
Total Return 12m
26.64%
#52 in Peer-Group
Total Return 5y
-81.23%
#93 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 67.47 USD |
| 52 Week Low | 34.28 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 90.20 |
| Buy/Sell Signal +-5 | 1.88 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IRON (26.6%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: IRON vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IRON
| Total Return (including Dividends) | IRON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.29% | 3.64% | 4.08% |
| 3 Months | 64.63% | 23.43% | 19.65% |
| 12 Months | 26.64% | -7.41% | 12.88% |
| 5 Years | -81.23% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | IRON | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 54.8% | 30.3% | 86.9% |
| 3 Months | 88.6% | 79.4% | 97.2% |
| 12 Months | 11.4% | -87.3% | 46% |
| 5 Years | -53.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th74.50 | 5.45% | 5.01% |
| 3 Month | %th71.50 | 33.38% | 37.59% |
| 12 Month | %th74.50 | 36.77% | 12.19% |
| 5 Years | %th53.00 | -76.79% | -90.58% |
FAQs
Does Disc Medicine (IRON) outperform the market?
Yes,
over the last 12 months IRON made 26.64%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months IRON made 64.63%, while XBI made 23.43%.
Performance Comparison IRON vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IRON vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.9% | 5.2% | -10.6% | 14% |
| US NASDAQ 100 | QQQ | 6.1% | 5.2% | -11.9% | 16% |
| German DAX 40 | DAX | 3.8% | 7.4% | -22.6% | -6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.4% | 4% | -14.9% | 6% |
| Hongkong Hang Seng | HSI | 7.1% | 6.8% | -30.8% | -10% |
| India NIFTY 50 | INDA | 6.9% | 9.3% | -10% | 29% |
| Brasil Bovespa | EWZ | 11.4% | 7.4% | -26.6% | 24% |
IRON vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 7.2% | 7.2% | -14.1% | 4% |
| Consumer Discretionary | XLY | 5.9% | 6.8% | -2.8% | 10% |
| Consumer Staples | XLP | 7.2% | 9.4% | -9.6% | 19% |
| Energy | XLE | 4% | 4.1% | -4.1% | 24% |
| Financial | XLF | 6.8% | 5.7% | -14.3% | -1% |
| Health Care | XLV | 5.3% | 8.3% | -0.6% | 32% |
| Industrial | XLI | 5.1% | 4.4% | -17.6% | 1% |
| Materials | XLB | 5% | 5% | -14% | 20% |
| Real Estate | XLRE | 6.4% | 9.9% | -10% | 15% |
| Technology | XLK | 5.9% | 2.4% | -14.8% | 18% |
| Utilities | XLU | 5.1% | 6.5% | -12.9% | 4% |
| Aerospace & Defense | XAR | 5.6% | 2.8% | -28.7% | -22% |
| Biotech | XBI | 2.3% | 5.7% | -0.9% | 34% |
| Homebuilder | XHB | 2.6% | 1% | -6.2% | 21% |
| Retail | XRT | 5.6% | 6.5% | -5% | 16% |
IRON vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 5.7% | 4.00% | 4.41% | 33% |
| Natural Gas | UNG | 9.2% | 17.5% | 17.8% | 32% |
| Gold | GLD | 6.3% | 9.5% | -25.5% | -13% |
| Silver | SLV | 5.2% | 7.7% | -24.3% | 7% |
| Copper | CPER | -3.1% | -4.1% | -31.5% | 4% |
IRON vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 5.9% | 7.6% | -6.1% | 29% |
| iShares High Yield Corp. Bond | HYG | 6.2% | 8.1% | -7.1% | 17% |